Clinical study of first-line endocrine therapy for type ER+/PR+ and ER+/PR- advanced breast cancer

Zhang, MW; Yan, M; Lv, HM; Niu, LM; Zeng, HA

Yan, M (corresponding author), Henan Canc Hosp, 127 Dongming Rd, Zhengzhou, Peoples R China.

ANNALS OF PALLIATIVE MEDICINE, 2021; 10 (1): 238

Abstract

Background: This study was designed to evaluate the relationship between estrogen receptor (ER) and progesterone receptor (PR) expression status and c......

Full Text Link